We are live on ! Find out more
ORGO icon

Organogenesis Holdings

31 hedge funds and large institutions have $11.8M invested in Organogenesis Holdings in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

91% more capital invested

Capital invested by funds: $6.17M → $11.8M (+$5.63M)

55% more funds holding

Funds holding: 2031 (+11)

0.85% more ownership

Funds ownership: 0.89%1.74% (+0.85%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

Holders
31
Holders Change
+11
Holders Change %
+55%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
6
Reduced
6
Closed
5
Calls
$16M
Puts
Net Calls
+$16M
Net Calls Change
+$210K

ORGO Hedge Fund Activity: Q2 2019 in Review

31 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q2 2019, worth a combined $11.8M — up 91% from $6.17M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ORGO positions and 5 closed out — a net gain of 11 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $3.58M. The largest seller was Goldman Sachs, exiting entirely with an estimated $761K sold.

  • 31 institutional investors held Organogenesis Holdings (ORGO) as of Q2 2019, up from 20 in Q1 2019.
  • Funds reported $11.8M of Organogenesis Holdings stock for Q2 2019, up 91% quarter-over-quarter.
  • 16 funds opened new Organogenesis Holdings positions in Q2 2019 and 5 closed out, a net change of +11 holders.
  • The largest Organogenesis Holdings buyer in Q2 2019 was BlackRock, an estimated $3.58M added.
  • The largest Organogenesis Holdings seller in Q2 2019 was Goldman Sachs, an estimated $761K sold.

Based on aggregated 13F filings for Q2 2019.